Article
Epidermal growth factor receptor as an adverse survival predictor in squamous cell carcinoma of the penis.
Human pathology - 1 Mar 2017
Silva Amancio Alice Muglia Thomaz da, Cunha Isabela Werneck da, Neves José Ivanildo, Quetz Josiane da Silva, Carraro Dirce Maria, Rocha Rafael Malagoli, Zequi Stenio Cássio, Cubilla Antonio Leopoldo, da Fonseca Francisco Paulo, Lopes Ademar, Cunha Maria do Perpétuo Socorro Saldanha da, Lima Marcos Venício Alves, Vassallo José, Guimarães Gustavo Cardoso, Soares Fernando Augusto
Abstract excerpt
Penile carcinoma (PC) is more frequent in underdeveloped countries, generally is diagnosed at an advanced stage when therapeutic options are restricted, and thus is associated with high morbidity/mortality rates. Recent studies have demonstrated clinical benefits with epidermal growth factor receptor (EGFR)-targeted therapy in patients with PC, although there is no test that provides accurate patient selection....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
